UPDATED Aug 28, 2025
Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
NEUP | US$12.21 | 76.4% | n/a | US$19.2m | US$19.50 | PE3.9x | E29.4% | n/a | ||
2675 | CN¥16.71 | -4.9% | 40.1% | CN¥13.5b | CN¥18.40 | PE85.7x | E29.4% | 0% | ||
600812 | CN¥6.33 | -3.4% | 32.4% | CN¥10.9b | CN¥7.30 | PE60.8x | E29.3% | 0.5% | ||
DB | CA$0.14 | 3.8% | 107.7% | CA$77.9m | n/a | PE5.9x | E29.1% | n/a | ||
2688 | CN¥7.10 | -2.3% | 90.9% | CN¥5.3b | n/a | PE36.3x | E29.0% | 1.4% | ||
SCLP | UK£0.10 | 3.4% | -40.0% | UK£107.9m | n/a | PE-6.9x | E28.9% | n/a | ||
4584 | JP¥255.00 | 1.2% | 87.5% | JP¥11.5b | JP¥450.00 | PE38.8x | E28.9% | n/a | ||
KZIA | US$7.73 | 5.9% | -60.5% | US$8.7m | US$14.13 | PS5.3x | E28.8% | n/a | ||
ATHA | US$0.40 | 0.3% | -87.1% | US$15.8m | n/a | PB0.5x | E28.8% | n/a | ||
1873 | HK$2.66 | 7.3% | 350.8% | HK$4.9b | HK$3.20 | PE29.8x | E28.7% | 0% | ||
SKAN | CHF 61.80 | -9.1% | -22.4% | CHF 1.4b | CHF 84.00 | PE85.9x | E28.6% | 0.6% | ||
IOBT | US$1.58 | -10.7% | 2.6% | US$110.7m | US$9.00 | PB65.4x | E28.5% | n/a | ||
RMDA | ج.م4.28 | 1.4% | 82.9% | ج.م6.5b | ج.م7.30 | PE15.6x | E28.4% | 1.2% | ||
GXI | €42.44 | -6.1% | -58.1% | €1.5b | €66.84 | PE23.2x | E28.3% | 0.09% | ||
A068270 | ₩167,900.00 | -3.4% | -9.7% | ₩38.0t | ₩217,513.14 | PE75.2x | E28.2% | 0.4% | ||
AGY | UK£0.08 | -8.0% | 86.0% | UK£390.3m | n/a | PS6.9x | E28.0% | n/a | ||
603707 | CN¥11.32 | -2.7% | 0.09% | CN¥18.5b | CN¥15.80 | PE24.9x | E27.9% | 0.9% | ||
SDZ | CHF 50.36 | 2.3% | 35.6% | CHF 21.7b | CHF 49.46 | PE119.2x | E27.9% | 1.1% | ||
DNLI | US$15.65 | 2.8% | -35.9% | US$2.3b | US$31.50 | PB2.2x | E27.7% | n/a | ||
CNTA | US$16.56 | -5.5% | 27.0% | US$2.2b | US$31.90 | PS148x | E27.7% | n/a | ||
ABBV | US$207.92 | -0.8% | 6.5% | US$367.6b | US$215.70 | PE98.7x | E27.6% | 3.2% | ||
PEB | NZ$0.14 | 5.3% | 35.9% | NZ$139.0m | n/a | PS6.3x | E27.5% | n/a | ||
CLDX | US$22.38 | 1.6% | -44.0% | US$1.5b | US$55.62 | PS256.7x | E27.3% | n/a | ||
ATNM | US$1.74 | 1.8% | -8.9% | US$54.9m | US$5.00 | PB2.9x | E27.1% | n/a |